Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 5.90
-0.10 (-1.67%)
Jun 5, 2026, 3:56 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 299.52 million as of June 5, 2026.
Market Cap
299.52M
Enterprise Value
289.16M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.90
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 299.52M, an increase of 97.05%. That is a compound annual growth rate of 107.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 299.52M | 81.43% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 859.92M |
| Racura Oncology | 505.16M |
| Clinuvel Pharmaceuticals | 450.32M |
| Starpharma Holdings | 317.97M |
| Orthocell | 206.91M |
| Recce Pharmaceuticals | 148.93M |
| Actinogen Medical | 129.28M |
| Nyrada | 120.03M |